CHR11, a chromatin-remodeling factor essential for nuclear proliferation during female gametogenesis in Arabidopsis thaliana by Huanca-Mamani,  W. et al.
CHR11, a chromatin-remodeling factor essential for
nuclear proliferation during female gametogenesis
in Arabidopsis thaliana
Wilson Huanca-Mamani*, Marcelina Garcia-Aguilar*, Gloria Leo´n-Martı´nez*, Ueli Grossniklaus†‡,
and Jean-Philippe Vielle-Calzada*§¶
*Laboratory of Reproductive Development and Apomixis, Department of Genetic Engineering, Centro de Investigacio´n y de Estudios Avanzados–Unidad
Irapuato, Apartado Postal 629, CP 36500, Irapuato, Guanajuato, Mexico; †Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724;
and ‡Institute of Plant Biology and Zurich–Basel Plant Science Center, University of Zurich, Zollikerstrasse 107, CH-8008 Zurich, Switzerland
Communicated by Luis Herrera-Estrella, National Polytechnic Institute, Guanajuato, Mexico, September 19, 2005 (received for review May 9, 2005)
Chromatin-remodeling factors regulate the establishment of tran-
scriptional programs during plant development. Although 42
genes encoding members of the SWI2SNF2 family have been
identified in Arabidopsis thaliana, <10 have been assigned a
precise function on the basis of a mutant phenotype, and none
have been shown to play a specific role during the gametophytic
phase of the plant life cycle. A. thaliana chromatin-remodeling
protein 11 (CHR11) encodes an imitation of switch (ISWI)-like
chromatin-remodeling protein abundantly expressed during fe-
male gametogenesis and embryogenesis in Arabidopsis. To deter-
mine the function of CHR11 in wild-type plants, we introduced a
hairpin construct leading to the production of double-stranded
RNA, which specifically degraded the endogenous CHR11mRNA by
RNA interference (RNAi). Transcription of the RNAi-inducing hair-
pin RNA was driven by either a constitutive cauliflower mosaic
virus 35S promoter (CaMV35S) acting at most stages of the sporo-
phytic phase or a newly identified specific promoter acting at the
onset of the female gametophytic phase (pFM1). All adult trans-
formants that constitutively lacked sporophytic CHR11 activity
showed reduced plant height and small cotyledonary embryos
with limited cell expansion. In contrast, RNAi lines in which CHR11
was specifically silenced at the onset of female gametogenesis
(megagametogenesis) had normal height and embryo size but had
defective female gametophytes arrested before the completion of
the mitotic haploid nuclear divisions. These results show that
CHR11 is essential for haploid nuclear proliferation during megaga-
metogenesis and cell expansion during the sporophytic phase,
demonstrating the functional versatility of SWI2SNF2 chromatin-
remodeling factors during both generations of the plant life cycle.
imitation of switch proteins  megagametophyte  RNA interference 
seed development  functional megaspore
The accessibility of DNA to transcription factors or other typesof interacting molecules is regulated by enzymatic complexes
that modify nucleosomal structure by means of ATP-dependent
chromatin-remodeling or histone modification (1). ATP-
dependent chromatin-remodeling factors are multisubunit com-
plexes that alter the chromatin structure by changing the confor-
mational state of the nucleosome. These structural changes are
accomplished without covalent modification and can be involved in
either the activation or the repression of transcription (2). Members
of the SWI2SNF2 family of ATP-dependent proteins share an
ATPase domain that is essential for their chromatin-remodeling
activity. In addition, SWI2SNF2 proteins have a large variety of N-
and C-terminal domains that are often involved in their interaction
with other members of specific chromatin-associated complexes.
The largest eukaryotic group of SWI2SNF2, ATP-dependent,
chromatin-remodeling proteins is the imitation of switch (ISWI)
subfamily. Originally identified in Drosophila (3, 4), ISWI members
are distinguished from other SWI2SNF2 proteins by the presence
of the SANT domain in their C-terminal region. The SANT domain
was originally identified in several metazoan proteins that include
SWI3, ADA2, N-CoR TFIIIB, and ISWI (5). From yeast to
humans, different portions of the SANT domain are required for
interaction either with histone deacetylasesacetyltransferases (the
N-terminal portion) or directly with chromatin (the C-terminal
portion) (6–8). ISWI proteins have been shown to accomplish
many different functions, including transcriptional activation and
repression, the assembly of chromatin structure, the replication of
heterochromatin, and the cohesion of sister chromatids (9).
Chromatin-remodeling factors have been shown to regulate the
establishment of transcriptional programs at many developmental
stages of the plant life cycle. Although 42 genes encoding SWI2
SNF2 proteins have been identified in the genome of Arabidopsis
thaliana [including members of all conserved subfamilies SNF2,
DDM1, ISWI, CHD, and SRCAP (www.chromdb.org)] (10), 10
have been assigned a precise function on the basis of a mutant
phenotype (11), and none have been shown to play a direct and
specific role during the gametophytic phase of the life cycle. Several
SWI2SNF2 proteins are known to be involved in the regulation of
epigenetic mechanisms of plant development. For example, muta-
tions in DECREASED IN DNAMETHYLATION 1 (DDM1) cause
a 70% reduction of genomic cytosine methylation and lead to
morphological abnormalities in the course of inbreeding because of
the accumulation of genetic and epigenetic alterations (12–15).
Similarly, DRD1 encodes a chromatin-remodeling factor involved
in RNA-guided DNA cytosine methylation (16). In contrast,MOR-
PHEUS MOLECULE 1 (MOM1) is required for the maintenance
of transcriptional gene silencing but does not affect regular meth-
ylation patterns (17).GYMNOSPICKLE encodes an SWI2SNF2-
like protein of the CHD subfamily that acts as a repressor of
meristematic genes and embryonic fate (18, 19). Three additional
SWI2SNF2 family members have been implicated in the temporal
regulation of key developmental transitions during the plant life
cycle. SPLAYED (SYD) controls the transition between vegetative
and reproductive development and is required for normal carpel
and ovule formation (20). syd mutants show a wide range of
pleiotropic effects, indicating that specific SWI2SNF2 members
regulate a wide range of transcriptional events. Recently, SYD was
shown to control cell fate in the shoot apical meristem by directly
regulating the transcription of the master regulator WUSCHEL
(21). AtBRAHMA controls plant size and flowering time through
repression of a photoperiod-dependent flowering pathway (22).
Finally, PHOTOPERIOD-INDEPENDENT EARLY FLOWER-
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ING 1 (PIE1) is the only ISWI family gene that has been function-
ally characterized in flowering plants. pie1 loss-of-function mutants
show premature flowering in noninductive photoperiods indepen-
dently of FLOWERING LOCUS C (FLC), a floral repressor acting
at the intersection of multiple floral regulatory pathways (23).
In this article, we report that CHR11, a constitutively expressed
gene that encodes a member of the ISWI class of chromatin-
remodeling proteins, participates in developmental processes dur-
ing the diploid (sporophytic) and the haploid (gametophytic) phase
of the Arabidopsis life cycle. To determine the function of CHR11,
we introduced a hairpin construct in wild-type plants that leads to
the production of double-stranded RNA, which specifically de-
graded the endogenous CHR11 mRNA by RNA interference
(RNAi). Transcription of the RNAi-inducing hairpin RNA was
driven either by a constitutive promoter acting at most stages of the
sporophytic phase or by a specific promoter acting at the onset of
the female gametophytic phase. All adult transformants that con-
stitutively lacked sporophyticCHR11 activity showed reduced plant
height and small cotyledonary embryos with limited cell expansion.
In contrast, RNAi lines in which CHR11 was specifically silenced at
the onset of megagametogenesis had normal height and embryo
size but had defective megagametophytes arrested before comple-
tion of the mitotic haploid nuclear divisions. Our results assign
sporophytic and gametophytic functions to a gene encoding a
member of the ISWI family of chromatin-remodeling factors.
Materials and Methods
Plant Material. Plants were grown on a 3:1:1 mixture of Mix3-
Sunshine (SunGro, Bellevue, WA), vermiculite, and perlite (vol
volvol ratio) containing 1.84 kgm3 of 14-14-14 slow-release
fertilizer (Osmocote, Sierra, Marysville, OH) under greenhouse
conditions or in a Percival incubator (Percival Scientific, Perry, IA)
at 19°C with a photoperiod of 16 h of light and 8 h of dark. Primary
transformant seedlings were selected by using 0.05% of BASTA
herbicide. Subsequent transformant generations were selected in
Murashige and Skoog (MS) medium containing 10 gml glufosi-
nate ammonium (Crescent chemical, Islandia, NY) in a Percival
incubator under the same photoperiod conditions.
RNA Isolation and Analysis. Total RNA was isolated by grinding
tissue in liquid nitrogen in the presence of TRIzol (Invitrogen).
For RT-PCR analysis, 5 g of total RNA from developing
siliques was used to synthesize first-strand cDNA by using an
oligo(dT) primer (Sigma). The following primers were used for
specific cDNA amplification: CHR11 (At3g06400), CHR11-
sense5 (5-TTACGGATCTGTCGAGTC-3) and CHR11-
antisense5 (5-TTACGGAAGAGAAGTCTAC-3); CHR17
(At5g18620), CHR17-sense2 (5-AGGCTTGTGTTGAATC-
CAT-3) and CHR17-antisense2 (5-GAGAAGTCGGAGA-
CAATG-3); and ACT11 (At3g12110), ACT11-sense (5-
TTCAACACTCCTGCCATG-3) and ACT11-antisense (5-
TGCAAGGTCCAAACGCAG-3). Agarose gels stained with
ethidium bromide were blotted onto Hybond N membranes
and hybridized at 65°C with a [32P]cDNA probe specific to each
gene tested. After exposure (3 days), autoradiograms were
digitally scanned, and the intensity of the signals was assessed by
using LABSWORKS 3.0.02 (Microsoft). For Northern blot analysis,
20 g of total RNA was isolated and processed as described in
ref. 24. For detection and analysis of small RNA fragments, total
RNA from developing flowers was enriched for low-molecular-
weight RNAs by using Hamilton’s solution, as described in refs.
25 and 26. A total of 60 g of low-molecular-weight RNA was
separated in 15% polyacrylamide8 M urea gels, electroblotted
onto a ZETA-PROBE membrane (Bio-Rad) overnight at 24 V
and 4°C, and crosslinked by using UV irradiation. The mem-
branes were hybridized at 65°C to a 570-bp randomly primed,
32P-labeled cDNA fragment corresponding to the CHR11 coding
region.
Generation of RNAi Plasmids. A 542-bp cDNA fragment correspond-
ing to nucleotides 1244–1786 of the CHR11 coding region was
amplified by RT-PCR and cloned in TOPO-PCRII (Invitrogen).
For cDNA amplification, we used following the primers: CHR11-
sense4 (5-CGAACCATGGTCTAGACGAAGAAGGAGAC-
CATAC; containing restriction sites NcoI and XbaI in boldface)
and CHR11-antisense4 (TTGGCGCGCCGGATCCTTGCAA-
GTCGACTTGTGG; containing restriction sites AscI and BamHI
in boldface). After digesting with NcoI and AscI, the amplified
CHR11 fragment was cloned in pFGC5941 in sense orientation
(27). To identify the insertion site in enhancer detector line ET499,
thermal asymmetric interlaced PCR (28) was performed as de-
scribed in ref. 29. To isolate the pFM1 promoter, primers
pET499-S1 (5-TAAAGCTTCATACTAGCATGTATCCAC;
containing the restriction site HindIII in boldface) and pET499-
AS1 (5-TAGGATCCGGTGGAACTTTATCGGTTT; contain-
ing the restriction site BamHI in boldface) were used to amplify an
880-bp genomic fragment in the 5 region of At4g12250. The
fragment was subsequently cloned in TOPO-PCRII and pBI101.2
(30). To generate the pFM1::CHR11-RNAi cassette, primers
p499-S3 (5-GCGAATTCATACTAGCATGTATCCAC; contain-
ing the restriction site EcoRI in boldface) and p499-AS2 (5-
CATGCCATGGTGGAACTTTATCGGTTT; containing the re-
striction site NcoI in boldface) were used to amplify pFM1 from
genomic DNA. The pFGC5941 plasmid (27) was digested with
EcoRI and NcoI to excise the CaMV35S promoter, and the pFM1
promoter was inserted into the same plasmid by using the EcoRI
and NcoI restriction sites.
In Situ Hybridization. A specific 156-bp fragment corresponding to
a portion of the CHR11 3 UTR was amplified by PCR using
primers CHR11-sense5 (5-TTACGGATCTGTCGAGTC) and
CHR11-antisense5 (5-TTACGGAAGAGAAGTCTAC) and
subsequently cloned in TOPO-PCRII. The resulting plasmid was
linearized with SstI (antisense) and BamHI (sense) and used for
generating digoxigenin-labeled probes. In situ hybridization was
performed as described in ref. 31.
Histological Analysis. For semithin sections, mature seeds were
fixed in 3% glutaraldehyde for 2 h, rinsed in 50 mM cacodylate
buffer, and postfixed in 2% osmium tetroxide (in the same
buffer). After dehydration in an acetone series, specimens were
embedded in Spurr’s resin, sectioned at thicknesses of 1 and 2
m on a Leica-Ultracut-R ultramicrotome (Deerfield, IL), and
observed on a Leica-DMR microscope under a bright field. For
whole-mount observations, individual gynoecia were dissected
longitudinally by using hypodermic needles (1-ml insulin sy-
ringes, Becton Dickinson) and processed as described in ref. 32.
-Glucuronidase (GUS) staining assays were conducted as
described in ref. 33. The surface area and total length of a group
of at least 20 wild-type orCHR11-RNAi embryos were measured
by using the image processing and analysis feature in JAVA
(IMAGE-J), as described in ref. 34.
Results and Discussion
CHR11 Is Abundantly Expressed During the Sporophytic and Gameto-
phytic Phases. On the basis of the presence of the SANT domain,
three genes belonging to the ISWI family have been identified in
Arabidopsis: CHR11 (At3g06400), CHR17 (At5g18620), and
PIE1 (At3g12810; www.chromdb.org). Fig. 1 illustrates the pre-
dicted domain structures of the proteins encoded by these three
genes and indicates their degree of amino acid similarity, taking
CHR11 as a reference. Like CHR17 and PIE, CHR11 has the
SNF2 and HEL-C domains that together constitute the SWI
SNF ATPase domain present in all SWI2SNF2 chromatin-
remodeling proteins. The C-terminal portion of all three pro-
teins harbors the SANT domain characteristic of ISWI-like
proteins. Although CHR11 and CHR17 show a high degree of
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amino acid similarity in all three domains, PIE1 has limited
similarity with both proteins. Publicly available expression profiles
generated by microarray analysis indicate that CHR11 and CHR17
are constitutively expressed (www.genevestigator.ethz.ch); how-
ever, CHR11 is invariably expressed at significantly higher levels
than CHR17, being 2 more abundant in rosette leaves and up to
4 more abundant in mature flowers and stems (35). We con-
firmed the constitutive expression of both genes by RT-PCR
analysis (data not shown).
To determine the spatial and temporal pattern of expression of
CHR11, we characterized the mRNA localization patterns of
CHR11 by in situ hybridization. To avoid the localization of CHR17
mRNA, digoxigenin-labeled probes were generated by using a
distinctive portion of the CHR11 3 UTR. In the developing ovule,
CHR11 was initially expressed in all cells of the young nucellus,
including the functional megaspore (Fig. 2A). After the initiation of
megagametogenesis, CHR11 mRNA was localized in most cells of
the ovule, including the integuments, the developing megagameto-
phyte, and the funiculus. In mature ovules, CHR11 expression was
particularly strong in the cellularized megagametophyte (Fig. 2B).
After double fertilization, CHR11 expression persisted in the
developing embryo and the free nuclear endosperm until seed
maturity (Fig. 2 C–E). CHR11 mRNA was also abundantly ex-
pressed in developing male gametophytes and mature pollen grains
(Fig. 2F) but not in the tapetum or other sporophytic tissues of the
fully differentiated anther. These results indicate that CHR11 is
abundantly expressed in both sporophytic and gametophytic tissues
throughout reproductive development.
Generation of Constitutive CHR11-RNAi Lines and Analysis of RNA
Levels. To determine a possible sporophytic function of CHR11 in
Arabidopsis, a 542-bp fragment of the CHR11 cDNA was cloned
into a pFGC5941 RNAi vector in both sense and antisense orien-
tation and used to transform wild-type Columbia plants (27, 32). In
pFGC5941, transcription of a partial CHR11 sequence is driven by
a 35S promoter of the cauliflower mosaic virus (CaMV35S) and
results in posttranscriptional gene silencing. A total of 42 adult
primary transformants were generated, all of which showed re-
duced height when compared with the wild type, a defect that was
consistently maintained in the T2 and T3 generations. To determine
a possible relationship between a decrease in CHR11 transcript
levels and the observed defective phenotype, RNA was extracted
from developing floral buds and flowers of BASTA-resistant
CHR11-RNAi T2 lines and used for RNA gel blot analysis. Com-
pared with wild-type plants, all five T2 lines analyzed showed
substantial decrease in the transcript levels of CHR11 (Fig. 3A).
Polyacrylamide gels were used to detect the presence of short
interfering RNA fragments (siRNAs) corresponding to CHR11.
siRNAs corresponding to CHR11 were detected in T2-1 and T2-2,
Fig. 2. Localization of CHR11 mRNA by in situ hybridization. (A–F) Hybrid-
izations with antisense probe. (A) Developing ovule at the end of megasporo-
genesis. (B) Mature ovule with a fully differentiated megagametophyte. (C)
Seed at the globular embryo stage. (D) Seed at the early heart embryo stage.
(E) Mature seed with a fully differentiated cotyledonary embryo. (F) Mature
pollen. (G–J) Hybridizations with sense probe. (G) Mature ovule with a fully
differentiated megagametophyte. (H) Mature pollen. (I) Seed at the transition
embryo stage. (J) Mature seed with a fully differentiated cotyledonary em-
bryo. CC, central cell; E, embryo; EA, egg apparatus; FM, functional megas-
pore; FNE, free nuclear endosperm; S, suspensor. (Scale bars: A–D and F–I, 20
m; E and J, 40 m.)
Fig. 3. Accumulation of CHR11 transcripts, the presence of 21-bp small RNAs,
and specific CHR11 silencing in constitutive CHR11-RNAi T2 lines. (A) Expres-
sion analysis of five CHR11-RNAi T2 lines and a wild-type control (WT). CHR11
mRNA abundance is shown (Upper) and the detection of siRNAs correspond-
ing to CHR11 is shown (Middle). Control rRNA in ethidium bromide gel is also
shown (Bottom). (B) Posttranscriptional gene silencing is specific to CHR11.
RNA extracted from wild-type siliques (lanes 1 and 2) or T3-2 CHR11-RNAi
siliques (lanes 3 and 4) and containing globular to heart stage embryos (lanes
1 and 3) or mature cotyledonary embryos (lanes 2 and 4). After cDNA synthesis,
PCR amplification was performed with primers specific to CHR11, CHR17, or
ACT11. Agarose gels were blotted and probed with a corresponding gene.
ACT11 was used as positive control.
Fig. 1. Organization and comparison of ISWI-like proteins in Arabidopsis.
Locations of conserved domains with significant homologies are indicated by
boxes: SNF2 (light gray), HEL-C (dark gray), and SANT (black). The percentages
indicate the degree of amino acid similarity for each conserved domain, taking
CHR11 as a reference. Numbers below each protein indicate the initial and
final codon of the corresponding domains.
Huanca-Mamani et al. PNAS  November 22, 2005  vol. 102  no. 47  17233
PL
A
N
T
BI
O
LO
G
Y
two lines showing strong defects in height but not in wild-type plants
or other CHR11-RNAi T2 lines, confirming that the absence of
mRNA expression can be associated with the degradation of the
corresponding transcript (Fig. 3A). The absence of siRNA detection
in plants showing defective phenotypes could be explained by a fast
siRNA turnover in lines with multiple T-DNA insertions (27).
Because the homology between CHR11 and CHR17 is 89% at the
nucleic acid level in the region targeted, we performed RT-PCR in
the wild-type line and in the selected line CHR11-RNAi T3-2 lines
showing small embryos. To assess the levels of gene expression, we
blotted the RT-PCR and hybridized the resulting membranes with
radiolabeled CHR11- or CHR17-specific probes. Although a slight
decrease of 15% in signal intensity was detected in embryos of
CHR11-RNAi lines (Fig. 3B), CHR11 expression was reduced to
10% at both developmental stages tested, demonstrating that in
CHR11-RNAi lines, posttranscriptional gene silencing mainly af-
fects CHR11.
Plant Height and Cell Size Are Reduced in Constitutive CHR11-RNAi
Lines. Primary CHR11-RNAi transformants were partially stunted
and their maximum height was significantly lower than in the wild
type. Although wild-type individuals reached a maximum mean
height of 54.18 cm (5 cm, n 11),CaMV35S::CHR11-RNAi lines
had a maximum mean height of 39.2 cm (7.5 cm, n  8; Fig. 4 A
and B). To determine whether the defect originated early during
development, whole-mounted mature embryos from the wild type
and the T4 generation of the previously selected lines (CHR11-
RNAi T4-1 and T4-2) were analyzed to compare their size on the
basis of the estimation of their area and their linear length, including
the radicle and the cotyledons. Although wild-type embryos have
a mean length of 992.4 m (42.5 m, n  20) and a mean
maximum surface area of 7,950 m2 (578 m2, n 20), CHR11-
RNAi lines had lengths between 837 and 883.2 m (52.3 and
53.2 m for T4-1 and T4-2, respectively, n  20) and maximum
surface areas ranging between 6,013 and 6,714 m2 (667 and
514 m2 for T4-1 and T4-2, respectively, n 20; Fig. 4 C and D).
To determine the cytological nature associated with these size
differences, we analyzed semithin sections of fixed mature cotyle-
dons in ungerminated embryos. No differences in the overall
pattern of cell division between wild type and CHR11-RNAi
embryos were identified. The same number of cell layers and an
indistinguishable number of cells per layer were found in mature
cotyledons of both samples; however, cells of defective embryos
were smaller than those of the wild type not only in the cotyledons
but also in the radicle and the meristem. These differences were
particularly evident in the L1 layer of the cotyledons (Fig. 4 E and
F). Although wild-type L1 cells had a mean surface area of 2,447
182 m2, L1 cells in mature embryos of line T4-2 had a mean
surface area of 579  202 m2. All differences in plant height,
embryo length, embryo surface area, and L1 cell surface area were
confirmed to be statistically significant by using 2 analysis. Overall,
these results indicate that the activity of CHR11 is necessary for
normal cell expansion during late embryogenesis.
pFM1 Is a Specific Promoter Driving Expression During Megagame-
togenesis. ET499 was identified as an enhancer detector line with
uidA (GUS) reporter gene expression in the functional megaspore
and the developing megagametophyte (36, 37). A genomic se-
quence flanking the 3 border of the enhancer detector Ds trans-
poson element was rescued by using thermal asymmetric interlaced
Fig. 4. Plant height and cell size are reduced in constitutive CHR11-RNAi
lines. (A) An adult wild-type plant. (B) An adult plant of CHR11-RNAi T2-2
showing reduced height. (C) A mature cotyledonary wild-type embryo. (D) A
mature cotyledonary embryo of CHR11-RNAi T4-2 showing reduced length
and surface area. (E) A semithin transversal section of a wild-type cotyledon in
a mature embryo. (F) A semithin transversal section of an embryo in CHR11-
RNAi T4-2 showing reduced cell expansion. (Scale bars: C andD, 500m; E and
F, 100 m; G and H, 30 m.)
Fig. 5. The pFM1 promoter specifically drives expression during megaga-
metogenesis. (A) Genomic localization of the enhancer detector element in
ET499. The element inserted in the intergenic region separating At4g112250
and At4g12260 is shown. The numbers indicate the genomic region that was
subcloned and used to generate the pFM1::uidA construct. (B–D) GUS expres-
sion in developing megagametophytes of pFM1::uidA transformants. (B) GUS
expression at the end of megasporogenesis. (C) GUS expression in the func-
tional megaspore. (D) GUS expression at the micropylar end of a four-nucleate
megagametophyte. (Scale bars: 30 m.)
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PCR. Sequence analysis showed that the Ds element was inserted
763 bp upstream of the transcription initiation site of a gene
encoding a putative nucleotide sugar epimerase (At4g12250; Fig.
5A). We confirmed that the pattern of GUS expression in ET499
reflects the pattern of expression of At4g12250 by showing that a
880-bp genomic fragment (named pFM1) is sufficient to drive
reporter gene expression in the functional megaspore in plants
transformed with a pFM1::uidA translational fusion. The genomic
region defining pFM1 is composed of the first 763 bp located
upstream of the At4g12250 transcription initiation site and the first
117 bp of the transcribed sequence. pFM1::uidA transformants
showed initial GUS expression in the functional megaspore at the
onset of megagametogenesis (Fig. 5 B and C) in the developing
megagametophyte (Fig. 5D). The pattern of expression persisted in
the cellularized megagametophyte but rapidly diminished after
double fertilization. GUS expression was absent from all vegetative
tissues tested, including seedlings, roots, leaves, stems, and floral
organs. These results indicate that pFM1 is a specific promoter
acting at the initial stages of megagametogenesis in the functional
megaspore and probably drives expression throughout the gameto-
phytic phase of the Arabidopsis life cycle.
CHR11 Is Essential for Haploid Mitotic Progression During Female
Gametogenesis. Although cytological evidence indicates that
CaMV35S can often cause RNAi-induced posttranscriptional gene
silencing in the developing megagametophyte by acting in the
sporophytic cells of the ovule (32), CaMV35S-driven cell autono-
mous gene silencing has not been demonstrated in the gameto-
phytic phase. Although CHR11 mRNA is abundantly localized in
the megagametophyte, lines in which CHR11 was posttranscrip-
tionally silenced by using a CaMV35S promoter did not show
defects during gametophytic development or early seed formation.
To determine the specific function of CHR11 during megagame-
togenesis, we replaced the CaMV35S constitutive promoter by
pFM1 in the RNAi-inducing plasmid pFGC5941. By transforma-
tion through the floral-dip method, 45 primary transformants were
generated, none of which showed visible defects during vegetative
growth, root development, or floral organogenesis; however, 8 of 45
adult transformants showed semisterility. As shown in Table 1, all
pFM1::CHR11-RNAi lines showed a frequency of ovule abortion
between 44.3% (T1-19) and 51.4% (T1-32). Developmental defects
in fully penetrant mutants carrying a single insertion and affecting
megagametophyte development but not microgametogenesis are
expected to occur at a frequency of 50%. Four lines (T2-17, T2-19,
T2-29, and T2-32) were selected for subsequent genetic and cyto-
logical analysis after determining that these lines contained a single
T-DNA insertion, according to Southern blot analysis. Reciprocal
crosses to wild-type plants showed that male transmission was
normal but that the transmission efficiency of the T-DNA through
female gametes was 2% in all four lines tested (data not shown).
Semisterile lines had a variable proportion of ovules showing
abnormal phenotypes but no obvious defects in pollen formation.
All lines underwent normal and synchronized megasporogenesis
(Fig. 6 A and F). After differentiation of the functional megaspore,
about half of the ovules divided mitotically three times and gave rise
to normally cellularized megagametophytes (Fig. 6 B–D), as is
observed during wild-type development. By contrast, within the
same gynoecium, the nucellus of close to 50% of mature ovules in
lines pFM1 T1-17, pFM1 T1-19, and pFM1 T1-26 had a single
conspicuous cell closely resembling the functional megaspore (Ta-
ble 1). Interestingly, this cell enlarged and partially reabsorbed the
adjacent nucellar cells (Fig. 6G). The three other semisterile lines
(including T1-29 and T1-32) showed close to 50% abnormal
megagametophytes in which the functional megaspore divided
Table 1. Ovule abortion and female gametophyte arrest in pFM1::CHR11-RNAi lines
pFM1::CHR11-RNAi
lines
No. of
T-DNA
insertions
% Aborted
ovules
% Female gametophyte arrest*
1N 2N 4N 8N
T1-17 1 45.0 (67) 45.0 (67) 0 0 0
T1-19 1 44.3 (125) 44.3 (125) 0 0 0
T1-26 ND 51.2 (20) 51.2 (20) 0 0 0
T1-29 1 52.3 (80) 7.3 (11) 13.9 (21) 28.5 (43) 3.3 (5)
T1-32 1 51.4 (127) 36.4 (90) 0.8 (2) 0.8 (2) 0.4 (1)
T1-33 ND 46.8 (81) 45.0 (78) 1.2 (2) 0 0
pFM1-blank ND 1.1 (2) 0 0 0 0
N, number of haploid nuclei; ND, not determined.
*The number of aborted ovules or arrested gametophytes is shown in parentheses.
Fig. 6. Megagametophyte development and absence of
CHR11 expression in pFM1::CHR11-RNAi lines. Wild-type and
pFM1::CHR11-RNAi gynoecia were either fixed, cleared, and
viewed under Nomarski optics, or processed for CHR11mRNA in
situ hybridization. (A–E) Wild-type ovules; (F–J) pFM::CHR11-RNAi
ovules. (A) Wild-type ovule at the onset of megagametogenesis.
(B) Wild-type two-nucleate megagametophyte. (C) Wild-type
four-nucleate megagametophyte. (D) Wild-type cellularized
megagametophyte. (E) CHR11 mRNA localization in the func-
tional megaspore of a wild-type ovule. (F) Ovule of line T1-29
pFM1::CHR11-RNAi at the onset of megagametogenesis. (G) Ma-
ture ovule of line T1-29 pFM1::CHR11-RNAi showing an arrested
one-nucleate megagametophyte. (H) Mature ovule of line T1-29
pFM1::CHR11-RNAi showing an arrested two-nucleate megaga-
metophyte. (I) Mature ovule of line T1-29 pFM1::CHR11-RNAi
showing an arrested four-nucleate megagametophyte. (J) Ab-
sence of CHR11 mRNA localization in the functional megaspore
of apFM1::CHR11-RNAi T1-29 ovule. FM, functional megaspore;.
Nuc, nucellus. (Scale bars: A–D, 30 m; E–J, 10 m.)
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mitotically one (Fig. 6H), two (Fig. 6I), or three times with no
subsequent cellularization. Wild-type plants lacking the CHR11-
RNAi construct showed normal CHR11 mRNA localization in the
ovule and the developing megagametophyte (Fig. 6E). In contrast,
the ovule of line pFM1 T1-29 showed CHR11 expression in
sporophytic cells, including the nucellus, but not in the functional
megaspore or the developing megagametophyte (Fig. 6J), indicat-
ing thatCHR11was specifically silenced in the female gametophytic
phase. The frequency of ovule abortion in pFM1::CHR11-RNAi
lines indicates that the phenotype of pFM1::CHR11-RNAi lines is
highly penetrant and gametophytic, with little or no influence from
CHR11 activity that could be provided by diploid sporophytic cells
neighboring the developing female gametophyte. Because haploid
nuclear proliferation occurs in a syncytium and cellularization takes
place after the formation of an 8-nucleate megagametophyte, it is
reasonable to suggest that the activity of CHR11 is cell autonomous
during female gametogenesis. Evidence showing that RNAi factors
transported from the nucellus are sufficient to cause CaMV35S-
driven posttranscriptional silencing in the megagametophyte sug-
gest either that the level of expression of CHR11 in the sporophytic
cells is not sufficient to trigger gametophytic silencing or that factors
causingCHR11 silencing are degraded before reaching the megaga-
metophyte (32).
The activity of ISWI-related remodeling factors has proven
essential for modifying the structure of chromatin during repro-
ductive development in several eukaryotic organisms, including
yeast (38) and the sea urchin (39). In the mouse, Snf2h/ embryos
show growth arrest at the preimplantation stage, indicating that the
activity of this ISWI-related protein is essential for cell proliferation
during embryogenesis (40). Our results indicate that CHR11 reg-
ulates similar growth-related programs at several developmental
stages of Arabidopsis life cycle. A biochemical link between cell
expansion and cell cycle regulation has been suggested to depend
on the interaction of plant retinoblastoma homologues with mem-
bers of the E2F family of transcription factors (41). Although
several E2F-like genes control the cell cycle in Arabidopsis (42),
other members, such as AtE2Ff, have been shown to repress cell
expansion (43). The retinoblastoma protein and some of its homo-
logues act as suppressors of E2F-like protein activity by recruiting
chromatin-remodeling factors of the SWI2SNF2 family in both
plants and animals (41). Remarkably, the retinoblastoma homo-
logue has been shown to control nuclear proliferation in the
megagametophyte (44), although several other genes have been
also shown to control the gametophytic cell cycle (45–48). An
interesting possibility is that CHR11 could act as a negative regu-
lator of one or several members of the E2F family in the Arabi-
dopsis, promoting nuclear proliferation during megagametogenesis
and cell expansion during embryogenesis. Although this control
could be exerted through the effect of endoreduplication or other
mechanisms affecting cell size (49), a detailed elucidation of the
cellular pathways regulated by CHR11 will require the determina-
tion of its genetic and biochemical interactions with specific mo-
lecular partners. Our findings open the possibility of elucidating the
specific role that the modification of chromatin structure plays in
the development and evolution of the gametophytic phase in
flowering plants.
We thank Daphne´ Autran and Luis Herrera-Estrella for helpful discus-
sions during preparation of the manuscript. This work was supported by
Consejo Nacional de Ciencia y Technologı´a (CONACYT) Grant B34324
and Z029 and a grant from the Howard Hughes Medical Institute (to
J.-P.V.-C.) and, in part, by grants from the Cold Spring Harbor Presi-
dent’s Council and the Janggen-Poehn Foundation (to U.G.). W.H.-M.
was the recipient of a graduate scholarship from the Organization of
American States (OEA) and the Ministry of Foreign Affairs of Mexico.
G.L.-M. is the recipient of a graduate scholarship from CONACYT.
J.-P.V.-C. is an International Scholar of the Howard Hughes Medical
Institute.
1. Emerson, B. (2002) Cell 109, 267–270.
2. Kingston, R. E. & Narlikar, G. J. (1999) Genes Dev. 13, 2339–2352.
3. Becker, P. B., Tsukiyama, T. & Wu, C. (1994) Methods Cell Biol. 44, 207–223.
4. Tsukiyama, T., Becker, P. B. & Wu, C. (1994) Nature 367, 525–532.
5. Aasland, R., Stewart, A. & Gibson, T. (1996) Trends Biochem. Sci. 21, 87–88.
6. Guenther, M. G., Barak, O. & Lazar, M. A. (2001) Mol. Cell Biol. 21, 6091–6101.
7. You, A., Tong, J.K., Grozinger, C.M. & Schreiber, S.L. (2001) Proc. Natl. Acad.
Sci. USA 98, 1454–1458.
8. Sterner, D. E., Wang, X., Bloom, M. H., Simon, G. M. & Berger, S. L. (2002)
J. Biol. Chem. 277, 8178–8186.
9. Dirscherl, S. S. & Krebs, J. E. (2004) Biochem. Cell Biol. 82, 482–489.
10. Verbsky, M. L. & Richards, E. J. (2001) Curr. Opin. Plant Biol. 4, 494–500.
11. Hsieh, T. F. & Fischer, R. L. (2005) Annu. Rev. Plant Biol. 56, 327–351.
12. Vongs, A., Kakutani, T., Martienssen, R. A. & Richards, E. J. (1993) Science
260, 1926–1928.
13. Kakutani, T., Jeddeloh, J. A., Flowers, S. K, Munakata, K. & Richards, E. J.
(1996) Proc. Natl. Acad. Sci. USA 93, 12406–12411.
14. Jeddeloh, J. A., Stokes, T. L. & Richard, E. J. (1999) Nat. Genet. 22, 94–97.
15. Brzeski, J. & Jerzmanowski, A. (2003) J. Biol. Chem. 278, 823–828.
16. Kanno, T., Mette, M. F., Kreil, D. P, Aufsatz, W., Matzke, M. & Matzke, A. J.
(2004) Curr. Biol. 14, 801–805.
17. Amedeo, P., Habu, Y., Afsar, K., Scheid, O. M. & Paszkowski, J. (2000) Nature
405, 203–206.
18. Ogas, J., Kaufmann, S., Henderson, J. & Somerville, C. (1999) Proc. Natl. Acad.
Sci. USA 96, 13839–13844.
19. Eshed, Y., Baum, S. & Bowman, J. (1999) Cell 99, 199–209.
20. Wagner, D. & Meyerowitz E. M. (2002) Curr. Biol. 12, 85–94.
21. Kwon, C. S., Chen, C. & Wagner, D. (2005) Genes Dev. 19, 992–1003.
22. Farrona, S., Hurtado, L., Bowman, J. L. & Reyes, J. C. (2004) Development
(Cambridge, U.K.). 131, 4965–4975.
23. Noh, Y. S. & Amasino, R. M. (2003) Plant Cell 15, 1671–1682.
24. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning: A
Laboratory Manual (Cold Spring Harbor Lab. Press, Woodbury, NY), 2nd Ed.,
pp. 7.43–7.52.
25. Hamillton, A. J. & Baulcombe, D. C. (1999) Science. 286, 950–952.
26. Mette, M. F., Aufsatz, W., Van der Winden, J., Matzke, M. A. & Matzke, A. J.
(2000) EMBO J. 19, 5194–5201.
27. Kerschen, A., Napoli, C. A., Jorgensen, R. A. & Muller, A. E. (2004) FEBS Lett.
566, 223–228.
28. Liu, Y. G., Mitsukawa, N., Oosumi, T. & Whittier, R. F. (1995) Plant J. 8, 457–463.
29. Grossniklaus, U., Vielle-Calzada, J.-P., Hoeppner, M. A. & Gagliano, W. B.
(1998) Science 280, 446–450.
30. Jefferson, R. A., Kavanagh, T. A. & Bevan, M. W. (1987) EMBO J. 6, 3901–3907.
31. Vielle-Calzada, J.-P., Thomas, J., Spillane, C., Coluccio, A., Hoeppner, M. &
Grossniklaus, U. (1999) Genes Dev. 13, 2971–2982.
32. Acosta-Garcia, G. & Vielle-Calzada, J.-P. (2004) Plant Cell 16, 2614–2628.
33. Vielle-Calzada, J.-P., Baskar, R. & Grossniklaus, U. (2000) Nature 404, 91–94.
34. Abramoff, M. D., Magelhaes, P. J. & Ram, S. J. (2004)Biophotonics Int. 11, 36–42.
35. Zimmemrmann, P., Hirsch-Hoffmann, M., Hennig, L. & Gruissem, W. (2004)
Plant Physiol. 136, 2621–2632.
36. Sundaresan, V., Springer, P., Volpe, T., Haward, S., Jones, J. D., Dean, C., Ma,
H. & Martienssen, R. (1995) Genes Dev. 9, 1797–1810.
37. Grossniklaus, U., Moore, J. M., Brukhin, V., Gheyselinck, J., Baskar, R.,
Vielle-Calzada, J.-P., Baroux, C., Page, D. R. & Spillane, C. (2003) Plant
Biotechnology 2002 and Beyond, ed. Vasil, I. (Kluwer, Dordrecht, The Neth-
erlands), pp. 309–314.
38. Gelbart, M. E., Bachman, N., Delrow, J., Boeke, J. D. & Tsukiyama, T. (2005)
Genes Dev. 19, 942–954.
39. Medina, R., Gutierrez, J., Puchi, M., Imschenetzky, M. & Montecino, M. (2001)
J. Cell Biochem. 83, 554–562.
40. Stopka, T. & Skoultchi, A. (2003) Proc. Natl. Acad. Sci. USA 100, 14097–14102.
41. Reyes, J., Hennig, L. & Gruissem, W. (2002) Plant Physiol. 130, 1090–1101.
42. De Velyder, L., Beeckman, T., Beemster, G. T. S., de Almeida Engler, J.,
Ormenese, S., Maes, S., Naudts, M., Van Der Schueren, E., Jacqmard, A.,
Engler, G. & Inze´, D. (2002) EMBO J. 21, 1360–1368.
43. del Pozo, J. C., Boniotti, M. B. & Gutierrez, C. (2002) Plant Cell 14, 3057–3071.
44. Ebel., C., Mariconti, L. & Gruissem, W. (2004) Nature 429, 776–780.
45. Springer, P. S., McCombie, W. R., Sundaresan, V. & Martienssen, R. A. (1995)
Science 12, 877–880.
46. Pischke, M. S., Jones, L. G., Otsuga, D., Fernandez, D. E., Drews, G. N. &
Sussman, M. R. (2002) Proc. Natl. Acad. Sci. USA 99, 15800–15805.
47. Kwee, H. S. & Sundaresan, V. (2003) Plant J. 36, 853–866.
48. Shi, D.-Q., Liu, J., Xiang, Y.-H., Ye, D., Sundaresan, V. & Yang, W.-C. (2005)
Plant Cell 17, 2340–2354.
49. Sugimoto-Shirasu, K. & Roberts, K. (2003) Curr. Opin. Plant Biol. 6, 544–553.
17236  www.pnas.orgcgidoi10.1073pnas.0508186102 Huanca-Mamani et al.
